During the past decade, Cleveland Cord Blood Center conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Cleveland Cord Blood Center" #1 collaborator was "National Heart, Lung, and Blood Institute (NHLBI)" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Cleveland Cord Blood Center" are "Acute Erythroid Leukemia" (1 trials), "Acute Lymphoblastic Leukemia" (1 trials), "Acute Megakaryoblastic Leukemia" (1 trials), "Acute Myeloid Leukemia" (1 trials) and "Chronic Myelogenous Leukemia, BCR-ABL1 Positive" (1 trials). Many other conditions were trialed in "Cleveland Cord Blood Center" in a lesser frequency.

Most popular intervention types in "Cleveland Cord Blood Center" are "Biological" (2 trials), "Drug" (1 trials), "Procedure" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Cyclophosphamide" (1 trials), "Dilanubicel" (1 trials), "Fludarabine" (1 trials), "HPC, Cord Blood" (1 trials) and "Thiotepa" (1 trials). Other intervention names were less common.

The vast majority of trials in "Cleveland Cord Blood Center" are 1 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Cleveland Cord Blood Center". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Cleveland Cord Blood Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Cleveland Cord Blood Center, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".